针对多发性骨髓瘤的生物标志物导向治疗
1Liverpool Hospital, University of New South Wales, Sydney.
Current opinion in oncology
|September 9, 2024
概括
针对多发性骨髓瘤的个性化医疗正在取得进展. 生物标志物如t(11;14) 转位预测对向治疗的反应,如BCL-2抑制剂,超越一种适合所有人的治疗方法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多发性骨髓瘤在患者的治疗结果和分子形状上表现出显著的异质性.
- 目前的治疗方法通常采用一种适合所有人的方法,未能解决个体患者或疾病特征.
研究的目的:
- 审查在多发性骨髓瘤治疗中向个性化医疗的转变.
- 突出预测生物标志物在定制治疗中的作用.
- 讨论新兴的向疗法及其预测标记.
主要方法:
- 评估已确定的预后生物标志物 (细胞遗传风险,脆弱性) 作为预测工具.
- 基于已识别的分子漏洞进行针对性疗法的调查.
- 专注于预测对特定药物的反应的生物标志物,如BCL-2抑制剂.
主要成果:
- 细胞遗传风险和脆弱状态正在评估预测潜力.
- 向疗法可以利用髓瘤细胞中的特定分子通路.
- 在15-20%的病例中,t(11;14) 转位是venetoclax反应的关键生物标志物.
结论:
- 研究正在积极探索venetoclax组合疗法和新的BCL-2抑制剂.
- 除了BCL-2,其他细胞通路正在作为多发性骨髓瘤新型向治疗的预测生物标志物进行研究.
更多相关视频
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
6.8K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.0K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K